The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
|Articles|October 1, 1996
The American Journal of Managed Care
- October 1996
- Volume 2
- Issue 9
The Psychopharmacology of Depression in the Managed Care Setting
Author(s)Norman Sussman, MD, Ricardo Castaneda, MD
Advertisement
Articles in this issue
about 30 years ago
The Influence of New Devices on the Costs of Interventional Proceduresabout 30 years ago
Patterns of Antidepressant Use and Their Relation to Costs of Careabout 30 years ago
Cost-Effective Treatment of DepressionAdvertisement
Related to this article
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Cleveland roundtable panelists across 4 disease states name access, not evidence, as the shared barrier to care.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Inconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
3
Medicaid Obesity GLP-1 Coverage May Offset Some Diabetes-Labeled Use
4
ACA Subsidies End for 189,000 Duplicate or Deceased Enrollees
5